Peiyuan Mu

机构：Fudan University Shanghai Cancer Center · ORCID：0000-0001-8666-5756

发表论文 13 篇 · 总被引 395 次 · h-index 7

代表论文

• Patient‐Derived Organoids from Colorectal Cancer with Paired Liver Metastasis Reveal Tumor Heterogeneity and Predict Response to Chemotherapy (2022 · Advanced Science · 被引 196)
• Newly developed 3D in vitro models to study tumor–immune interaction (2023 · Journal of Experimental & Clinical Cancer Research · 被引 78)
• Assay establishment and validation of a high-throughput organoid-based drug screening platform (2022 · Stem Cell Research & Therapy · 被引 54)
• Patient‐derived tumor organoids predict responses to irinotecan‐based neoadjuvant chemoradiotherapy in patients with locally advanced rectal cancer (2022 · International Journal of Cancer · 被引 28)
• Interferon-driven CAF reprogramming augments immunogenic response to neoadjuvant radiotherapy in colorectal cancer (2025 · Cell Reports Medicine · 被引 17)
• Unveiling radiobiological traits and therapeutic responses of BRAFV600E-mutant colorectal cancer via patient-derived organoids (2025 · Journal of Experimental & Clinical Cancer Research · 被引 9)